SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome

Maengjo Kim(Mayo Clinic), Michael J. Ackerman(Mayo Clinic in Florida)

Heart Rhythm O2

February 15, 2023

10.1016/j.hroo.2023.02.003

Cited by 11

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

|EP Europace|2011|899

TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy

|International Journal of Molecular Sciences|2021|33